Labcorp LH recently announced the launch and national availability of its blood biomarker test, Amyloid-Tau-Neurodegeneration (“ATN”) Profile. Physicians can now use the test with patients who are ...
Laboratory Corporation of America Holdings LH, popularly known as LabCorp, recently launched the Neurofilament Light Chain (NfL) blood test to facilitate the detection and verification of the signs of ...
Labcorp (NYSE:LH) on Wednesday announced the latest addition to its Alzheimer's testing portfolio: The pTau217 test, designed to identify phosphorylated tau 217 (pTau217), a key blood-based biomarker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback